Polyphosphoester-based cationic nanoparticles serendipitously release integral biologically-active components to serve as novel degradable inducible nitric oxide synthase inhibitors

  • Yuefei Shen
  • , Shiyi Zhang
  • , Fuwu Zhang
  • , Alexander Loftis
  • , Adriana Pavía-Sanders
  • , Jiong Zou
  • , Jingwei Fan
  • , John Stephen A. Taylor
  • , Karen L. Wooley

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

A degradable polyphosphoester (PPE)-based cationic nanoparticle (cSCK), which is integrated constructed as a novel degradable drug device, demonstrates surprisingly efficient inhibition of inducible nitric oxide synthase (iNOS) transcription, and eventually inhibits nitric oxide (NO) over-production, without loading of any specific therapeutic drugs. This system may serve as a promising anti-inflammatory agent toward the treatment of acute lung injury.

Original languageEnglish
Pages (from-to)5609-5614
Number of pages6
JournalAdvanced Materials
Volume25
Issue number39
DOIs
StatePublished - Oct 18 2013

Keywords

  • degradation
  • iNOS inhibition
  • integrated construction
  • polyphosphoester-based nanoparticle

Fingerprint

Dive into the research topics of 'Polyphosphoester-based cationic nanoparticles serendipitously release integral biologically-active components to serve as novel degradable inducible nitric oxide synthase inhibitors'. Together they form a unique fingerprint.

Cite this